A study of riluzole in the treatment of advanced stage or elderly patients with amyotrophic lateral sclerosis
暂无分享,去创建一个
[1] P. Benfield,et al. Riluzole. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in amyotrophic lateral sclerosis. , 1996, Drugs.
[2] P. Leigh,et al. Dose-ranging study of riluzole in amyotrophic lateral sclerosis , 1996, The Lancet.
[3] B. Brooks,et al. Clinical epidemiology of amyotrophic lateral sclerosis. , 1996, Neurologic clinics.
[4] P. Leigh,et al. Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II. , 1996, Lancet.
[5] B. Brooks,et al. El escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis , 1994, Journal of the Neurological Sciences.
[6] V. Meininger,et al. A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. , 1994, The New England journal of medicine.
[7] F. Norris,et al. Onset, natural history and outcome in idiopathic adult motor neuron disease , 1993, Journal of the Neurological Sciences.
[8] J. R. Brinkmann,et al. The natural history of amyotrophic lateral sclerosis , 1993, Neurology.
[9] D. B. Williams,et al. Motor neuron disease (amyotrophic lateral sclerosis). , 1991, Mayo Clinic proceedings.
[10] V. Meininger,et al. A double‐blind, placebo‐controlled trial of high doses of gangliosides in amyotrophic lateral sclerosis , 1989, Neurology.
[11] F. Norris,et al. The administration of guanidine in amyotrophic lateral sclerosis , 1974, Neurology.